Less than a year after obtaining an FDA approval for its first foray into pulsed field ablation, Medtronic has done it again.

Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic plc added a second U.S. FDA pulsed field ablation (PFA) device approval to its scorecard with the agency’s ...

Affera combines mapping technology with a catheter capable of performing radiofrequency and pulsed field ablation.

New FARAWAVETM NAV Ablation Catheter and FARAVIEWTM Software combine with OPAL HDxTM Mapping System to provide visualization ...

Boston Scientific's AVANT GUARD trial evaluates the FARAPULSE PFA System for treating persistent atrial fibrillation, pausing ...

SGMC Health recently announced Kamil Hanna, MD, a cardiac electrophysiologist, has successfully performed the first Farapulse ...

Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV ...

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...